Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show neuroprotective efficacy in human clinical trials or produced intolerable central nervous system adverse effects. The failure of these agents has been attributed to poor studies in animal models and to poorly designed clinical trials. We also speculate that NMDA receptor antagonism may have hindered endogenous mechanisms for neuronal survival and neuroregeneration. It remains to be proven in human stroke whether NMDA receptor antagonism can be neuroprotective.

Type

Journal article

Journal

Curr Mol Med

Publication Date

03/2004

Volume

4

Pages

131 - 136

Keywords

Animals, Brain Ischemia, Cell Survival, Disease Models, Animal, Excitatory Amino Acid Antagonists, Guanidines, Humans, Indoles, Ischemia, N-Methylaspartate, Neurons, Pipecolic Acids, Receptors, N-Methyl-D-Aspartate, Stroke